Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23829912 | 0.78 | TP53 (0.35) | TP53CYP1A2GAACYP2C9PKM | |
| Maleic Acid SCHEMBL718707 | 0.76 | HCAR2 (0.46) | TP53TSHRGAATDP1 | |
| Fumaric Acid SCHEMBL8181535 | 0.76 | HCAR2 (0.46) | TP53TSHRGAATDP1 | |
| SCHEMBL375633 | 0.76 | TP53 (0.47) | TP53TSHRCYP1A2GAACYP2C9 | |
| SCHEMBL26110798 | 0.73 | TP53 (0.44) | TP53TSHRCYP1A2GAACYP2C9 | |
| SCHEMBL76624 | 0.73 | — | — | |
| SCHEMBL4332630 | 0.71 | — | — | |
| SCHEMBL989972 | 0.71 | — | — | |
| SCHEMBL28632671 | 0.71 | — | — | |
| SCHEMBL634236 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3877390-A1 | SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMIA-1 (MCL-1) PROTEIN | Prelude Therapeutics, Incorporated (US) | 2021-09-15 | — | — | EP | disclosed |